Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Raynor

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|June 7, 2014
Exploring consumer opinions on the presentation of side-effects information in Australian Consumer Medicine Information leafletsVivien Tong, David K Raynor, Susan J Blalock, et al.
Drugs & Aging|May 6, 2011
How do the attitudes and beliefs of older people and healthcare professionals impact on the use of multi-compartment compliance aids?: a qualitative study using grounded theoryJacky Nunney, David K Raynor, Peter Knapp, et al.
The Journal of Pediatric Endocrinology|July 1, 1993
The new pharmacology of somatostatin and its multiple receptorsD H Coy, W A Murphy, K Raynor, et al.
BMJ Open|December 18, 2014
The design and user-testing of a question prompt list for attention-deficit/hyperactivity disorderRana Ahmed, David K Raynor, Kirsten J McCaffery, et al.
The Annals of Pharmacotherapy|May 18, 2005
Interpretation of medication pictograms by adults in the UKPeter Knapp, David K Raynor, Adel H Jebar, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|November 7, 2003
Patients' views of a pharmacist-run medication review clinic in general practiceDuncan R Petty, Peter Knapp, D K Raynor, et al.
Molecular Pharmacology|August 1, 1993
Mutation of an aspartate at residue 89 in somatostatin receptor subtype 2 prevents Na+ regulation of agonist binding but does not alter receptor-G protein associationH Kong, K Raynor, K Yasuda, et al.
The International Journal of Pharmacy Practice|February 20, 2013
Evaluating a combined (frequency and percentage) risk expression to communicate information on medicine side effects to patientsPeter Knapp, Peter Gardner, Brian McMillan, et al.
The Annals of Pharmacotherapy|February 11, 2000
Medicine information help lines: a survey of hospital pharmacy-based services in the UK and their conformity with guidelinesD K Raynor, J A Sharp, H Rattenbury, et al.
BMJ Quality & Safety|October 7, 2025
Widespread inappropriate prescribing for older people with reduced kidney function: what are the harms and how do we tackle them? A scoping review for primary careOwen Thomas, Liz Glidewell, Sarah Alderson, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|June 7, 2014
Exploring consumer opinions on the presentation of side-effects information in Australian Consumer Medicine Information leafletsVivien Tong, David K Raynor, Susan J Blalock, et al.
Drugs & Aging|May 6, 2011
How do the attitudes and beliefs of older people and healthcare professionals impact on the use of multi-compartment compliance aids?: a qualitative study using grounded theoryJacky Nunney, David K Raynor, Peter Knapp, et al.
The Journal of Pediatric Endocrinology|July 1, 1993
The new pharmacology of somatostatin and its multiple receptorsD H Coy, W A Murphy, K Raynor, et al.
BMJ Open|December 18, 2014
The design and user-testing of a question prompt list for attention-deficit/hyperactivity disorderRana Ahmed, David K Raynor, Kirsten J McCaffery, et al.
The Annals of Pharmacotherapy|May 18, 2005
Interpretation of medication pictograms by adults in the UKPeter Knapp, David K Raynor, Adel H Jebar, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|November 7, 2003
Patients' views of a pharmacist-run medication review clinic in general practiceDuncan R Petty, Peter Knapp, D K Raynor, et al.
Molecular Pharmacology|August 1, 1993
Mutation of an aspartate at residue 89 in somatostatin receptor subtype 2 prevents Na+ regulation of agonist binding but does not alter receptor-G protein associationH Kong, K Raynor, K Yasuda, et al.
The International Journal of Pharmacy Practice|February 20, 2013
Evaluating a combined (frequency and percentage) risk expression to communicate information on medicine side effects to patientsPeter Knapp, Peter Gardner, Brian McMillan, et al.
The Annals of Pharmacotherapy|February 11, 2000
Medicine information help lines: a survey of hospital pharmacy-based services in the UK and their conformity with guidelinesD K Raynor, J A Sharp, H Rattenbury, et al.
BMJ Quality & Safety|October 7, 2025
Widespread inappropriate prescribing for older people with reduced kidney function: what are the harms and how do we tackle them? A scoping review for primary careOwen Thomas, Liz Glidewell, Sarah Alderson, et al.
Pageof 13